Global Pharmaceuticals & Biotech Most Popular Stocks

Thiogenesis Therapeutics

Market Cap: CA$36.8m

A clinical-stage biopharmaceutical company, develops thiol-based therapeutic compounds to treat unmet pediatric medical needs.

Lipum

Market Cap: SEK 247.1m

A biopharmaceutical company, engages in the discovery and development of treatment for chronic inflammatory diseases in Sweden.

Kubota Pharmaceutical Holdings

Market Cap: JP¥3.9b

Develops portfolio of drugs and devices worldwide.

Advicenne

Market Cap: €22.3m

A specialty pharmaceutical company, develops, commercializes, and markets treatments for rare renal diseases in France and internationally.

Emyria

Market Cap: AU$39.8m

Engages in delivering and developing of treatments for mental health and select neurological conditions in Australia.

Karolinska Development

Market Cap: SEK 245.3m

A venture capital firm specializing in investments in growth capital, seed stage, and early stage companies.

Indofarma

Market Cap: Rp390.5b

Manufactures and sells pharmaceutical products in Indonesia and internationally.

Zelluna

Market Cap: NOK 255.7m

Develops T-cell receptor (TCR) cellular immunotherapy products for the treatment of solid cancers.

Microbix Biosystems

Market Cap: CA$35.6m

A life science company, develops and commercializes proprietary biological and technological solutions for human health and wellbeing in North America, Europe, and internationally.

Evaxion

Market Cap: US$25.5m

A clinical-stage biotech company, develops artificial intelligence-powered immunology vaccines.

Boundless Bio

Market Cap: US$25.5m

A clinical-stage oncology company, develops cancer therapeutics to address the unmet need of patients with oncogene amplified tumors by interrogating extrachromosomal DNA (ecDNA).

Passage Bio

Market Cap: US$25.4m

A genetic medicines company, develops gene therapies for central nervous system diseases.

Seoul Pharma

Market Cap: ₩35.7b

Manufactures and sells pharmaceutical products in South Korea and internationally.

Respiratorius

Market Cap: €21.7m

A research company, develops drug candidates for the treatment of cancer, chronic obstructive pulmonary disease (COPD), and asthma.

Kainos Medicine

Market Cap: ₩35.6b

Engages in research and development of various medicines for cancers, brain, and infectious diseases in South Korea and internationally.

MIRA Pharmaceuticals

Market Cap: US$25.2m

Operates as a pre-clinical-stage pharmaceutical development company with two neuroscience programs targeting a range of neurologic and neuropsychiatric disorders.

Initiator Pharma

Market Cap: SEK 236.2m

A clinical stage life science company, develops drugs targeting unmet medical needs within the central and peripheral nervous system.

Elicera Therapeutics

Market Cap: SEK 235.4m

A clinical stage immuno-oncology company, develops cell and gene therapies for immune-based cancer treatments in Sweden.

Little Green Pharma

Market Cap: AU$38.2m

Engages in the cultivation, production, and distribution of medicinal cannabis products in Australia and internationally.

GeneBioTech Ltd

Market Cap: ₩35.2b

Engages in the manufacture and sale of feed additives and functional food in South Korea.

MFC

Market Cap: ₩35.1b

Operates as a pharmaceutical company in South Korea.

PharmaTher Holdings

Market Cap: CA$34.6m

A specialty pharmaceutical company, develops and commercialize specialty pharmaceuticals exhibiting the adoption and permitting novel delivery methods to enhance patient outcomes.

Grace Breeding

Market Cap: ₪82.7m

An agro-tech company, develops nitrogenous and climate change stress relief products in Europe, the United States, South America, and Israel.

Enlivex Therapeutics

Market Cap: US$24.6m

Operates as a clinical-stage macrophage reprogramming immunotherapy company in Israel.

Original BioMedicals

Market Cap: NT$746.4m

A biotechnology company, chemical entities to solve unmet medical needs in Taiwan.

China Health Group

Market Cap: HK$190.1m

An investment holding company, researches and develops drugs, bio drugs, natural drugs, and synthetic drugs in the People’s Republic of China.

Moleculin Biotech

Market Cap: US$24.3m

A late-stage pharmaceutical development company, engages in the development of therapeutic candidates for the treatment of tumors and viruses.

Apimeds Pharmaceuticals US

Market Cap: US$24.3m

Operates as a clinical stage biopharmaceutical company in the United States.

Pharmaids Pharmaceuticals

Market Cap: ₹2.2b

Provides contract research and manufacturing services for pharma, biotech, agro, and chemical industries in India.

SenesTech

Market Cap: US$24.2m

Engages in the development and commercialization of a technology for managing animal pest populations through fertility control.

Isofol Medical

Market Cap: SEK 227.7m

Operates as a clinical stage biotech company.

Transgenic Group

Market Cap: JP¥3.6b

Develops, distributes, and licenses genetically modified animals and antibodies in Japan.

AccuStem Sciences

Market Cap: US$24.1m

A clinical stage diagnostics company, focuses on developing and commercializing a suite of novel genomic tests for oncology care.

Exicure

Market Cap: US$24.1m

Does not have significant operations.

Bioray Biotech

Market Cap: NT$733.7m

Engages in the research and development, manufacture, and sale of biological and health supplement products.

PeopleBio

Market Cap: ₩33.9b

A biotech company, develops bioproducts for diagnostic and treatment of protein misfolding diseases.